We are excited to announce that NeoMega36® has officially made its way to Norway! This marks the sixth country where our innovative solution is now in use, and we couldn’t be happier to welcome our first Norwegian customer.
Expanding into new markets is an important milestone, and we look forward to seeing NeoMega36 make an impact in even more countries soon. Thank you for the support—this journey is just getting started!
NeoMega36® is a food for special medical purposes enriched with ARA and DHA. Each dose contains 100 mg of ARA and 50 mg of DHA, in accordance with the ESPGHAN recommendations to support the unique needs of preterm infants during critical stages of development. Research has shown that ARA and DHA supplementation support normal eye development.
Stay tuned for more updates!